|Description||Annamycin liposomal is a liposome-encapsulated form of the semi-synthetic doxorubicin analogue annamycin with antineoplastic activity. Annamycin intercalates into DNA and inhibits topoisomerase II, resulting in the inhibition of DNA replication and repair and RNA and protein synthesis. Liposomal annamycin is less toxic and shows improved antitumor activity compared to annamycin.|
|Current Developer||Callisto Pharmaceuticals|
UBP1112 is a selective group III mGlu receptor antagonist (apparent Kd = 5.1 and 488 μM for group III and group II mGlu receptors respectively; IC50 > 1 mM for ...
Ondansetron HCl is a serotonin 5-HT3 receptor antagonist.
RD20000, a corticosteroid, is a topical antiinflammatory agent.
SB 228357 is a 5-HT2C/2B receptor antagonist (pKi = 7.0, 8.1 and 9.1 at 5-HT2A, 2B and 2C receptors, respectively) used in the treatment of irritable bowel synd...
Phenelzine sulfate, a non-selective hydrazine derivative inhibitor that has an irreversible function on monoamine oxidase, was effective to treat neurotic, atyp...
PSB-12062 is a potent and selective P2X4 antagonist (IC50= 1.38 μM for human P2X4) which has potential to be used as a therapeutic target for neutopathic pain, ...
AM-206 is a bio-active chemical but no detailed data has been published yet.
Methiocarb, also called as Mercaptodimethur, is a carbamate pesticide used in agriculture as insecticides and herbicides.